Total Payments
$2,315
2023 Payments
$14.66
Companies
29
Transactions
160
Medicare Patients
616
Medicare Billing
$47,559
Payment Breakdown by Category
Food & Beverage$2,315 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,315 | 160 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $339.17 | 26 | $0 (2021) |
| Novo Nordisk Inc | $232.31 | 15 | $0 (2022) |
| Merck Sharp & Dohme LLC | $187.70 | 14 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $175.33 | 13 | $0 (2022) |
| ABBVIE INC. | $165.07 | 9 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $161.18 | 11 | $0 (2022) |
| Amgen Inc. | $149.20 | 9 | $0 (2019) |
| GlaxoSmithKline, LLC. | $139.24 | 9 | $0 (2019) |
| PFIZER INC. | $138.18 | 10 | $0 (2021) |
| Lilly USA, LLC | $130.90 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.66 | 1 | Edwards Lifesciences Corporation ($14.66) |
| 2022 | $281.82 | 15 | ABBVIE INC. ($105.50) |
| 2021 | $276.35 | 17 | Novo Nordisk Inc ($60.95) |
| 2020 | $116.38 | 9 | SANOFI-AVENTIS U.S. LLC ($25.68) |
| 2019 | $826.21 | 58 | AstraZeneca Pharmaceuticals LP ($167.69) |
| 2018 | $489.85 | 38 | AstraZeneca Pharmaceuticals LP ($129.92) |
| 2017 | $309.42 | 22 | GlaxoSmithKline, LLC. ($112.02) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/28/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $14.66 | General |
| 11/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.12 | General |
| 06/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/09/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/31/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Diabetes | ||||||
| 05/23/2022 | Hologic, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diagnostics | ||||||
| 05/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Diabetes | ||||||
| 05/04/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: VACCINE | ||||||
| 04/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 04/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: DIABETES | ||||||
| 02/02/2022 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $19.73 | General |
| 09/28/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: VACCINE | ||||||
| 09/13/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Diabetes Care | ||||||
| 07/15/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Diabetes | ||||||
| 06/17/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: VACCINE | ||||||
| 06/01/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/28/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), ROTATEQ, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: VACCINE | ||||||
| 04/06/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 106 | 134 | $27,805 | $10,367 |
| 2021 | 6 | 242 | 306 | $51,321 | $18,706 |
| 2020 | 8 | 268 | 358 | $54,208 | $18,486 |
Total Patients
616
Total Services
798
Medicare Billing
$47,559
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $7,622 | $4,660 | 61.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 70 | $15,890 | $4,396 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 27 | $4,293 | $1,312 | 30.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 65 | 65 | $13,390 | $8,275 | 61.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 100 | $22,700 | $5,402 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 70 | $11,130 | $2,503 | 22.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 27 | 28 | $2,940 | $1,849 | 62.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 31 | 32 | $864.00 | $503.46 | 58.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 11 | 11 | $297.00 | $174.11 | 58.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 63 | 63 | $12,978 | $7,013 | 54.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 65 | 107 | $21,614 | $4,738 | 21.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 62 | 107 | $14,659 | $3,617 | 24.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 14 | 14 | $2,296 | $1,647 | 71.7% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 14 | 14 | $1,470 | $854.00 | 58.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 19 | $513.00 | $299.18 | 58.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 18 | 18 | $486.00 | $282.12 | 58.0% |
| 81003 | Automated urinalysis test | Office | 2020 | 13 | 16 | $192.00 | $35.85 | 18.7% |
About Dr. Audrey Goodwin, MD
Dr. Audrey Goodwin, MD is a Pediatrics healthcare provider based in Edmond, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1952661688.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Audrey Goodwin, MD has received a total of $2,315 in payments from pharmaceutical and medical device companies, with $14.66 received in 2023. These payments were reported across 160 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,315).
As a Medicare-enrolled provider, Goodwin has provided services to 616 Medicare beneficiaries, totaling 798 services with total Medicare billing of $47,559. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Edmond, OK
- Active Since 05/29/2012
- Last Updated 07/14/2017
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1952661688
Products in Payments
- FARXIGA (Drug) $256.82
- JARDIANCE (Drug) $122.09
- ANORO (Drug) $112.02
- Aimovig (Biological) $101.15
- Ozempic (Drug) $97.71
- JANUVIA (Drug) $94.82
- VRAYLAR (Drug) $88.71
- TRULICITY (Drug) $88.02
- TOUJEO (Drug) $77.42
- SYMBICORT (Drug) $71.13
- TEKTURNA (Drug) $68.98
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $65.94
- Creon (Drug) $59.57
- SOLIQUA 100/33 (Biological) $55.93
- GARDASIL 9 (Biological) $54.68
- Saxenda (Drug) $49.34
- Prolia (Biological) $48.05
- CONTRAVE (Drug) $47.66
- EUCRISA (Drug) $44.76
- ELIQUIS (Drug) $38.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Edmond
Kristin Lewis, Md, MD
Pediatrics — Payments: $10,568
Pediatrics $10,568
Emily Reed, M.d, M.D
Pediatrics — Payments: $10,486
Pediatrics $10,486
Dr. Sabrina Olay, Md, MD
Pediatrics — Payments: $5,560
Pediatrics $5,560
Jessica Yocum, M.d, M.D
Pediatrics — Payments: $2,695
Pediatrics $2,695
George Stephens, Md, MD
Pediatrics — Payments: $1,809
Pediatrics $1,809
Dr. Jonathan Roth, Md, MD
Pediatrics — Payments: $1,673
Pediatrics $1,673